| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 28,987 | 29,121 | 22,862 | 31,187 | | Cost of Revenue | 21,754 | 21,207 | 17,447 | 23,242 | | | Gross Profit | 7,233 | 7,914 | 5,415 | 7,945 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 3,599 | 3,173 | 3,208 | 2,433 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,179 | 3,276 | 3,416 | 3,535 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 455 | 1,465 | (1,209) | 1,977 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (56) | (5) | 135 | (39) | | Earnings Before Interest And Taxes | 912 | 2,347 | (317) | 2,144 | | Interest Expense | 866 | 887 | 840 | 1,270 | | Income Before Tax | 46 | 1,460 | (1,157) | 874 | | Income Tax Expense | (157) | 488 | 17 | 1,129 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,360 | 972 | (1,174) | (255) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 203 | 972 | (1,174) | (255) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $203 | $972 | ($1,174) | ($255) |
|
0.11% Nasdaq 0.00%
Income Statement
